Drug Research
BMS obtains FDA approval for Opdivo as bladder cancer treatment
The US FDA has approved Bristol Myers Squibbโs (BMS) Opdivo (nivolumab) as an adjuvant therapy for urothelial carcinoma (UC) patients at increased risk of...
Press Releases
Pfizer-BioNTech COVID-19 Vaccine COMIRNATY Receives Full U.S. FDA Approval for Individuals 16 Years and Older
Pfizer Inc. and BioNTech SE announced that the U.S. FDA approved the Biologics License Application (BLA) for COMIRNATYยฎ (COVID-19 Vaccine, mRNA) to prevent COVID-19...
Drug Research
McMaster, Sartorius Enter Biomanufacturing Partnership
Sartorius Stedim Biotech, an international partner of the biopharmaceutical industry, has entered into a partnership with McMaster University to improve manufacturing processes of antibody...
Press Releases
AGC Biologics Announces the Groundbreaking of its New Facility at its Copenhagen, Denmark Site
AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announces the groundbreaking of its new facility at its Copenhagen, Denmark site....
News
Clinerion patent for technology underpinning Patient Network Explorer is published
The new Clinerion patent underpins any medical EHR database infrastructure that incorporates a hybrid model of cloud-and-local server node installations at individual hospitals, as...
Press Releases
Zydus receives EUA from DCGI for ZyCoV-D, the only needle-free COVID vaccine in the world
Zydus Cadila announced that the company has received the Emergency Use Authorization (EUA) from the Drug Controller General of India (DCGI) for ZyCoV-D the...
Drug Research
Zydus partners with CHEMI of Italy to launch Enoxaparin Sodium Injection in the United States
Zydus Pharmaceuticals Inc, USA (a 100% subsidiary of Cadila Healthcare Limited (Zydus Cadila), a leading innovation-driven, global healthcare provider, has signed a license and...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read















